Trump’s NIH and FDA nominees advance to full Senate vote. Story by Gabrielle M. Etzel, Washington Examiner • 3w. T wo of President Donald Trump’s key public health nominations advanced at ...

President Trump’s nominees to head the National Institutes of Health (NIH) and Food and Drug Administration (FDA) cleared a key Senate committee largely along party lines Thursday, paving the ...

Key takeaways: The Senate HELP committee advanced the Trump administration’s nominations to lead the NIH and FDA. Last week, both nominees fielded questions on key issues, including vaccines and ...

The vote to confirm Jay Bhattacharya, MD, as NIH director was 12-11, entirely along party lines. The vote to confirm Marty Makary, MD, MPH, as FDA commissioner was a little more lopsided at 14-9 ...

Trump’s picks to run FDA and NIH win approval from Senate’s health committee. ... The committee voted 14-9 to advance Makary, ... The next step for the nominees is a vote by the full Senate, ...

Two of President Donald Trump's nominees selected to take over top health roles in the federal government helped launch a new scientific journal after facing censorship during the COVID-19 pandemic.

The NIH and FDA nominees are surprisingly strong. Democrats shouldn’t reflexively oppose these Trump nominees.

Republican members focused on the nominees' respective commitments to increase transparency in federal health agencies and advance President Donald Trump's Make America Healthy Again agenda.

In today's Pharmalittle roundup, an FDA office crunch, Trump's health agency picks advance to a full Senate vote, and more.

Drs. Jay Bhattacharya and Marty Makary progressed along partisan lines to a full Senate vote on their confirmations for NIH and FDA, respectively.

President Trump’s nominees to head the National Institutes of Health (NIH) and Food and Drug Administration (FDA) cleared a key Senate committee largely along party lines Thursday, paving the ...